FIELD: medicine, oncology, peptides.
SUBSTANCE: invention relates to a chimeric protein used in treatment of malignant lymphomas. Invention proposes chimeric protein consisting of two peptides representing inhibitor of cyclin kinases as an active fragment p16INK4a with amino acid sequence 84-13 or 84-106 as a therapeutic agent and the second peptide VP22 with sequence 140-301 of virus herpes simplex as a transporting agent. Advantage of the invention involves the development of preparation of high effectiveness of penetration into cells and possessing cytostatic and cytotoxic effects.
EFFECT: valuable medicinal properties of chimeric protein.
1 dwg, 2 ex
Authors
Dates
2007-04-20—Published
2004-11-22—Filed